Oct 8, 2026 02:11PM
May 28, 2026 12:45PM
May 28, 2026 12:30PM
May 18, 2026 12:15PM
May 18, 2026 12:15PM
Apr 27, 2026 11:50AM
Mar 26, 2026 12:48PM Tevogen Bio evaluates CRO acquisition worth over $20 million annually
Mar 25, 2026 02:21PM
Feb 27, 2026 02:20PM
Feb 27, 2026 02:20PM
Jan 30, 2026 03:00PM
Jan 30, 2026 03:00PM
Jan 12, 2026 09:03AM
Jan 12, 2026 09:00AM Tevogen Demonstrates Platform Scalability and Multi-Indication T Cell Pipeline Expansion in 2025
Nov 14, 2025 02:36PM
Nov 14, 2025 02:32PM
Sep 8, 2025 09:28AM
Sep 8, 2025 09:27AM
Sep 4, 2025 03:50PM
Sep 4, 2025 03:48PM
Sep 3, 2025 04:15PM Tevogen highlights COVID-19 treatment data for immunocompromised patients
Sep 3, 2025 04:15PM
Aug 19, 2025 03:40PM
Aug 18, 2025 05:50PM
Aug 11, 2025 11:59AM
Aug 11, 2025 11:58AM
Aug 11, 2025 09:28AM
Aug 8, 2025 11:37AM REPEAT - Tevogen Sees Significant Institutional Ownership Growth; 73% of Holders Increase Positions
Aug 6, 2025 03:59PM
Aug 6, 2025 03:59PM
Aug 5, 2025 02:32PM
Aug 5, 2025 02:32PM
Aug 1, 2025 03:58PM
Aug 1, 2025 03:57PM
Aug 1, 2025 03:32PM Tevogen Bio to receive $1 million grant for AI drug discovery expansion
Aug 1, 2025 03:30PM
Jul 30, 2025 12:45PM
Jul 30, 2025 12:41PM
Jul 28, 2025 11:54AM
Jul 28, 2025 11:52AM
Jul 18, 2025 12:39PM
Jul 18, 2025 12:36PM Tevogen.AI Receives International Patent Publication for AI Technology Predicting Immunologically Active Peptides
Jul 16, 2025 11:57AM
Jul 10, 2025 03:13PM
Jun 30, 2025 02:28PM
Jun 9, 2025 09:00AM
May 30, 2025 11:01AM
May 30, 2025 11:01AM
May 23, 2025 03:57PM Tevogen Bio (TVGN) expands TVGN 489 target population for patients 65+
May 23, 2025 03:49PM

1,201,662 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All